Social Responsibility

Search documents
GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
Globenewswire· 2025-05-14 20:10
Core Viewpoint - GENFIT has published its 2025 Extra-Financial Performance Report, highlighting its commitment to sustainable development and corporate social responsibility (CSR) in the biopharmaceutical sector, particularly focusing on rare and life-threatening liver diseases [1][2][3] Company Commitment to ESG - The establishment of a dedicated ESG Committee in 2021 has led to a structured approach to sustainability, with an annual roadmap translating into concrete actions and monitoring of key indicators [3] - In 2024, GENFIT enhanced its social and environmental responsibility efforts, including increased patient engagement and initiatives for gender equality in the workplace [3][4] - The company is preparing a compliance plan for non-financial reporting under the CSRD framework, despite the suspension of its transition plan to ESRS standards due to regulatory developments [3] Patient and Employee Engagement - GENFIT's initiatives, such as a breast cancer prevention campaign, demonstrate its commitment to improving the quality of life and working conditions for employees [5] - Patient advocacy efforts, particularly in the area of Acute-on-Chronic Liver Failure (ACLF), reflect the company's dedication to developing treatments that significantly improve patient lives [5] Long-term Value Creation - GENFIT recognizes the correlation between long-term financial performance and extra-financial performance, emphasizing the societal impact of its R&D programs and governance practices [6][7] - The company aims to create meaningful long-term value for patients, healthcare systems, employees, and shareholders through its commitment to innovative therapeutic solutions [7] Company Overview - GENFIT is a late-stage biopharmaceutical company focused on rare liver diseases, with a diverse and expanding R&D portfolio, including five assets under development for ACLF [8] - The company has a history of successful drug approvals, including Iqirvo® (elafibranor) for Primary Biliary Cholangitis, showcasing its expertise in drug development [8]
Boralex announces the election of its directors and highlights of its Annual Meeting of Shareholders
Globenewswire· 2025-05-14 19:26
MONTREAL, May 14, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) held its annual meeting of shareholders earlier today. During the meeting chaired by Alain Rhéaume, Chairman of the Board, shareholders elected directors and adopted the resolutions proposed. Mr. Rhéaume opened the meeting by outlining Boralex's highlights for the year 2024, during which the Company continued to stand out thanks to the agility and flexibility that have long characterized it. He pointed out that t ...
Cooper Standard Establishes Carbon Neutral Targets in Updated Corporate Responsibility Report
Prnewswire· 2025-05-14 12:30
NORTHVILLE, Mich., May 14, 2025 /PRNewswire/ -- Cooper Standard (NYSE: CPS) today announced the release of its 2024 Corporate Responsibility Report, titled "Transformation: Change is Constant," underscoring the Company's continued commitment to ethical business practices, environmental stewardship, philanthropic outreach, and financial strength. Notably, the 2024 report announces the Company's commitment to develop near-term science-based targets that will pave the way toward the Company's aspiration to bec ...
REMINDER: Boralex will release its 2025 first quarter financial results on May 14, at 9 a.m.
Globenewswire· 2025-05-12 13:30
MONTREAL, May 12, 2025 (GLOBE NEWSWIRE) -- Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) announces that the release of the 2025 first quarter results will take place on Wednesday, May 14, 2025, at 9 a.m. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time Wednesday, May 14, 2025, at 9 a.m. ET To attend the conference Webcast link: https://edge.media-server.com/mmc/p/3nwdfvm2 To attend the event by phone: Click he ...
HighCo: Shareholding as 04/30/2025
Globenewswire· 2025-05-07 08:14
Group 1 - The total number of shares as of April 30, 2025, is 22,284,457, with 21,473,617 actual voting rights [1] - The number of shares without voting rights is 810,840 as of April 30, 2025 [1] - The company has consistently reported the total number of shares and voting rights on a monthly basis, showing slight variations [1] Group 2 - HighCo is a marketing and communication expert that supports brands and retailers in transforming retail [3] - The company is listed in compartment C of Euronext Paris and has nearly 450 employees [3] - HighCo has achieved a Gold rating from EcoVadis, ranking in the top 5% of companies for CSR performance [3] Group 3 - Upcoming financial events include the publication of Q2 and H1 2025 Gross Profit on July 22, 2025, and the 2025 Half-year Earnings on September 10, 2025 [6] - HighCo is a component stock of several indices, including CAC® Small and Euronext® Tech Croissance [6]
Las Vegas Sands Continues Funding for Dress for Success Southern Nevada's Workforce Development Programs
Prnewswire· 2025-05-06 17:48
The $100,000 Sands Cares contribution underwrites organizational capacity building to enable services for unemployed and underemployed women.LAS VEGAS, May 6, 2025 /PRNewswire/ -- Las Vegas Sands (NYSE: LVS) has contributed $100,000 through the Sands Cares global community engagement program to Dress for Success® (DFS) Southern Nevada for its professional styling, job readiness, career coaching and financial literacy programs, which empower disadvantaged women to pursue economic independence through a varie ...
ABC arbitrage : General meeting of June 6 2025
Globenewswire· 2025-04-28 16:00
ABC arbitrage General meeting of June 6 2025 ABC arbitrage shareholders are invited to participate in the combined general meeting held on Friday 6 June 2025 from 10.30am at the Centorial Auditorium - 18 rue du Quatre Septembre - 75002 PARIS. The notice of meeting including the agenda and the text of the proposed resolutions was published in the French Compulsory Legal Announcements Journal (BALO) on Monday 28 April 2025. This notice along with all participation modalities are available on the company’s w ...
Blackbaud Unveils Latest Innovation for Corporate Social Impact
Prnewswire· 2025-04-09 13:00
Core Insights - Blackbaud hosted the YourCause® from Blackbaud® Corporate Social Impact Summit, gathering social good professionals and corporate leaders to discuss innovation and collaboration in corporate social responsibility [1][2] - The event highlighted themes of engagement, innovation, partnership, and impact, aiming to inspire attendees to drive meaningful change [2] Product Innovations - Blackbaud unveiled an innovation roadmap for YourCause, focusing on enhancing employee giving, volunteering, engagement, and grantmaking [2] - New features include Expedited Giving, which allows donations to be delivered to nonprofits up to 95% faster, and new payment modalities for easier employee engagement [5] - Streamlined event management tools and Mobile Check-In features are designed to enhance volunteer engagement [5] - AI integration is being utilized to improve grant application processes and workflows for corporate grantmakers [5] - YourCause is expanding globally to create inclusive experiences and enhance platform localization [5] - Partnerships with organizations like True Impact are providing customers with data to inform funding decisions [5] - The Blackbaud Impact Edge™ with built-in AI assistant aims to transform corporate social responsibility reporting from static to dynamic, enabling real-time insights [5] Customer Support and Training - Blackbaud offers comprehensive customer success, support, and training programs to ensure companies can effectively utilize the YourCause platform [3] - Support is available globally, with new training courses introduced regularly to focus on practical applications and best practices [3] Upcoming Events - Blackbaud will host a virtual Product Update Briefings event from May 6-9, 2025, to provide further insights into YourCause enhancements [4]
Limekiln Wind Farm, Scotland: Boralex’s First Production Site in the United Kingdom Now Operational
Globenewswire· 2025-04-01 11:00
For more information, please visit the Limekiln Wind Farm page on our website. Boralex accelerates its development in the United Kingdom The operation of Limekiln Wind Farm comes at a time of strong growth for Boralex in the UK. Since 2023, the Company has expanded its team from 10 to 23 renewable energy professionals and aims to recruit more than a dozen new employees by the end of the year in all departments. Two major milestones were reached in the past year, with the closing of financing and the signing ...